Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the best oversold NASDAQ stocks to buy now. On July 14, William Blair analyst Sami Corwin maintained a bullish stance on Ultragenyx ...

Around 3,500 FDA employees received termination emails; FDA Commissioner Marty Makary suggests lowering industry user fees ...

The incumbent, Supervisor Eric Lucan, isn’t running for reelection. Instead, the Novato Democrat is vying to succeed ...

Improved Station Access Created Via Partnership Between North River Leerink and Wheelock Street Capital in Collaboration with the City of Som ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Carlsmed Inc. launched its IPO at a price of $14 to $16 per share for 6.7 million shares, which would raise just over $100.5 ...

PDUFA date nears for GSK plc’s Blenrep (belantamab mafodotin), the U.S. FDA’s Oncologic Drugs Advisory Committee will decide July 17 on whether available data justify the return to market of the ...

Johnson & Johnson stock jumped early Wednesday after the health care giant beat second-quarter forecasts and raised its outlook.

NHS England agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile, Merck advanced a once-monthly PrEP pill ...

British engineering giant Rolls-Royce announced on Tuesday a $75 million investment to expand its manufacturing operations in ...